AVM
Arch Venture Management Portfolio holdings
AUM
$492M
1-Year Est. Return
38.31%
1 Year Est. Return
+38.31%
AUM
$299M
AUM Growth
+$92.9M
(+45%)
Holding
11
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Beam Therapeutics
BEAM
$2.2B
| $77.2M | 25.82% |
4,540,132
|
|
||
2
Vir Biotechnology
VIR
$783M
| $65.1M | 21.76% |
+12,916,663
|
|
||
|
MAZE
3
Maze Therapeutics
MAZE
$1.57B
| $50.6M | 16.91% |
4,120,053
|
|
||
|
RAPP
4
Rapport Therapeutics
RAPP
$1.16B
| $42.4M | 14.19% |
3,728,738
|
|
||
|
VERV
5
DELISTED
Verve Therapeutics
VERV
| $22.6M | 7.54% |
2,008,809
|
|
||
6
Lyell Immunopharma
LYEL
$359M
| $16.1M | 5.39% |
+1,820,634
|
|
||
7
Erasca
ERAS
$732M
| $14.1M | 4.71% |
11,055,554
|
|
||
8
Gossamer Bio
GOSS
$627M
| $9.91M | 3.31% |
8,055,916
|
|
||
9
Q32 Bio
QTTB
$26.3M
| $478K | 0.16% |
320,482
|
|
||
|
UBX
10
DELISTED
Unity Biotechnology
UBX
| $386K | 0.13% |
1,004,817
|
|
||
|
CERO
11
DELISTED
CERo Therapeutics
CERO
| $216K | 0.07% |
22,389
+21,284
|
|